Drug:
Reaction: NO ADVERSE EVENT
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26937599 |
US |
1 | |
Device issue, No adverse event, |
||||
ETEPLIRSEN, |
||||
| 102 | 26937605 |
US |
25 | 1 |
Intentional dose omission, No adverse event, |
||||
ETEPLIRSEN, ETEPLIRSEN, ENALAPRIL MALEATE, ENALAPRIL, ALBUTEROL SULFATE, |
||||
| 103 | 26937606 |
US |
9 | 1 |
Procedural pain, Device issue, Product dose omission issue, No adverse event, |
||||
ETEPLIRSEN, ETEPLIRSEN, ETEPLIRSEN, |
||||
| 104 | 26937617 |
US |
13 | 1 |
Product dose omission issue, No adverse event, |
||||
ETEPLIRSEN, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, MELATONIN, LISINOPRIL, LISDEXAMFETAMINE DIMESYLATE, FAMOTIDINE, |
||||
| 105 | 26937618 |
US |
25 | 1 |
Product dose omission issue, No adverse event, |
||||
ETEPLIRSEN, ETEPLIRSEN, CARVEDILOL, ENALAPRIL MALEATE, ENALAPRIL, EMPAGLIFLOZIN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 106 | 26937626 |
US |
6 | 1 |
Intentional dose omission, No adverse event, |
||||
ETEPLIRSEN, ERGOCALCIFEROL, ENALAPRIL MALEATE, ENALAPRIL, |
||||
| 107 | 26937633 |
US |
10 | 1 |
Product dose omission issue, No adverse event, |
||||
ETEPLIRSEN, ETEPLIRSEN, FLUTICASONE PROPIONATE, LISINOPRIL, LORATADINE, LORATADINE ORAL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, POLYETHYLENE GLYCOL 3350, PREDNISONE, SPIRONOLACTONE, ALBUTEROL SULFATE, |
||||
| 108 | 26937634 |
US |
20 | 1 |
Product dose omission issue, Product distribution issue, No adverse event, |
||||
ETEPLIRSEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, LISINOPRIL, FAMOTIDINE, CARVEDILOL, PREDNISONE, |
||||
| 109 | 26937635 |
US |
9 | 1 |
Product dose omission issue, No adverse event, |
||||
ETEPLIRSEN, ETEPLIRSEN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, SPIRONOLACTONE, PREDNISONE, PREDNISONE, LORATADINE, LORATADINE ORAL, LISINOPRIL, FERROUS SULFATE, FERROUS SULFATE, FLUTICASONE PROPIONATE, |
||||
| 110 | 26937657 |
US |
20 | 1 |
Device issue, Product dose omission issue, No adverse event, |
||||
ETEPLIRSEN, |
||||
| 111 | 26937667 |
US |
22 | 1 |
Product dose omission issue, No adverse event, |
||||
ETEPLIRSEN, LISINOPRIL, SPIRONOLACTONE, FAMOTIDINE, ESCITALOPRAM, CALCIUM CARBONATE, CALCIUM CARBONATE TABLET, CHEWABLE, |
||||
| 112 | 26937668 |
US |
26 | 1 |
Product dose omission issue, No adverse event, |
||||
ETEPLIRSEN, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, LISINOPRIL, SERTRALINE HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, |
||||
| 113 | 26937671 |
US |
21 | 1 |
Device issue, Product dose omission issue, No adverse event, Increased dose administered, |
||||
ETEPLIRSEN, ETEPLIRSEN, ETEPLIRSEN, ALBUTEROL SULFATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CARVEDILOL, FAMOTIDINE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 114 | 26937684 |
US |
16 | 2 |
Product dose omission issue, No adverse event, |
||||
ETEPLIRSEN, ETEPLIRSEN, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, GABAPENTIN, LOSARTAN POTASSIUM, LOSARTAN, SERTRALINE HYDROCHLORIDE, ERGOCALCIFEROL, |
||||
| 115 | 26937690 |
US |
20 | 1 |
Product dose omission issue, No adverse event, |
||||
ETEPLIRSEN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FAMOTIDINE, CALCIUM, LISINOPRIL, |
||||
| 116 | 26937703 |
US |
11 | 1 |
Product dose omission issue, No adverse event, |
||||
ETEPLIRSEN, |
||||
| 117 | 26937706 |
US |
23 | 1 |
Poor venous access, No adverse event, |
||||
ETEPLIRSEN, ETEPLIRSEN, CALCIUM CARBONATE, FAMOTIDINE, ESCITALOPRAM, LISINOPRIL, SPIRONOLACTONE, |
||||
| 118 | 26937712 |
US |
14 | 1 |
Device issue, Product dose omission issue, No adverse event, |
||||
ETEPLIRSEN, ETEPLIRSEN, |
||||
| 119 | 26937713 |
US |
18 | 1 |
Poor venous access, Device issue, Product dose omission issue, No adverse event, |
||||
ETEPLIRSEN, |
||||
| 120 | 26937718 |
US |
14 | 1 |
Product dose omission issue, No adverse event, |
||||
ETEPLIRSEN, ETEPLIRSEN, PREDNISONE, SERTRALINE HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DEXMETHYLPHENIDATE HYDROCHLORIDE, |
||||
| 121 | 26937886 |
US |
2 | |
Drug ineffective, No adverse event, |
||||
LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 122 | 26938008 |
US |
1 | |
Drug ineffective, No adverse event, |
||||
LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 123 | 26938455 |
US |
||
Incorrect dose administered, Device infusion issue, Device occlusion, No adverse event, |
||||
| 124 | 26938717 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 125 | 26938718 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 126 | 26938733 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 127 | 26938757 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 128 | 26938758 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 129 | 26938760 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 130 | 26938762 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 131 | 26938763 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 132 | 26938764 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 133 | 26938767 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 134 | 26938768 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 135 | 26938769 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 136 | 26938770 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 137 | 26938771 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 138 | 26938772 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 139 | 26938773 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 140 | 26938774 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 141 | 26938775 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 142 | 26938776 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 143 | 26938777 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 144 | 26938778 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 145 | 26938779 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 146 | 26938780 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 147 | 26938781 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 148 | 26938782 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 149 | 26938783 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 150 | 26938784 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 151 | 26938786 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 152 | 26938787 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 153 | 26938794 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 154 | 26938795 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 155 | 26938796 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 156 | 26938797 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 157 | 26938798 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 158 | 26938799 |
PR |
||
Radioisotope scan abnormal, No adverse event, |
||||
TETROFOSMIN, TECHNETIUM TC-99M, |
||||
| 159 | 26938836 |
US |
2 | |
Drug effect less than expected, No adverse event, |
||||
ABALOPARATIDE, |
||||
| 160 | 26938870 |
US |
65 | |
No adverse event, |
||||
TIRZEPATIDE, |
||||
| 161 | 26939975 |
US |
1 | |
Product delivery mechanism issue, Device information output issue, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 162 | 26940006 |
US |
2 | |
Product delivery mechanism issue, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 163 | 26940043 |
US |
2 | |
Product delivery mechanism issue, No adverse event, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 164 | 26931913 |
US |
66 | |
No adverse event, |
||||
TIRZEPATIDE, |
||||
| 165 | 26932239 |
US |
||
No adverse event, Device malfunction, Device malfunction, No adverse event, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 166 | 26932267 |
US |
||
Device malfunction, No adverse event, Device failure, No adverse event, Device failure, Device malfunction, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 167 | 26932339 |
US |
||
Device malfunction, Device malfunction, No adverse event, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 168 | 26932347 |
US |
1 | |
No adverse event, Device malfunction, No adverse event, Device malfunction, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 169 | 26932422 |
US |
2 | |
Incorrect dose administered, Liquid product physical issue, No adverse event, |
||||
ENSIFENTRINE, |
||||
| 170 | 26932740 |
US |
49 | |
Product dose omission issue, No adverse event, |
||||
TOLVAPTAN, TOLVAPTAN, AMOXICILLIN AND CLAVULANATE POTASSIUM, TOLVAPTAN, TOLVAPTAN, LISINOPRIL, LISINOPRIL, PREGABALIN, METHYLPREDNISOLONE, RIMEGEPANT SULFATE, PANTOPRAZOLE, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, MONTELUKAST SODIUM, |
||||
| 171 | 26932867 |
US |
72 | |
Device mechanical issue, Device difficult to use, No adverse event, |
||||
LEVALBUTEROL TARTRATE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, |
||||
| 172 | 26933031 |
US |
2 | |
Product storage issue, No adverse event, |
||||
DORZOLAMIDE HYDROCHLORIDE, |
||||
| 173 | 26933149 |
US |
||
Recalled product administered, No adverse event, |
||||
PREDNISOLONE ACETATE, |
||||
| 174 | 26934054 |
US |
89 | |
Product storage error, Product label issue, No adverse event, Product physical issue, Product container issue, |
||||
ENSIFENTRINE, |
||||
| 175 | 26927063 |
US |
||
Extra dose administered, Device delivery system issue, No adverse event, |
||||
BROMFENAC SODIUM, BROMFENAC SODIUM, |
||||
| 176 | 26927296 |
US |
||
Occupational exposure to product, Product physical issue, No adverse event, |
||||
LISDEXAMFETAMINE DIMESYLATE, |
||||
| 177 | 26927323 |
US |
1 | |
Product storage error, No adverse event, |
||||
DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 178 | 26927415 |
US |
75 | |
Drug dose omission by device, Device malfunction, Wrong technique in product usage process performed in error, Device deposit issue, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 179 | 26927454 |
US |
16 | 2 |
Off label use, No adverse event, |
||||
AVAPRITINIB, |
||||
| 180 | 26927537 |
US |
||
Incorrect dose administered by device, Device defective, Device failure, Device issue, No adverse event, |
||||
LIRAGLUTIDE, LIRAGLUTIDE, |
||||
| 181 | 26927786 |
US |
||
Recalled product administered, No adverse event, |
||||
LIRAGLUTIDE, |
||||
| 182 | 26927815 |
US |
64 | |
Recalled product administered, No adverse event, |
||||
LIRAGLUTIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, EMPAGLIFLOZIN, |
||||
| 183 | 26927839 |
US |
||
Product storage issue, No adverse event, |
||||
| 184 | 26927896 |
US |
||
Device issue, No adverse event, |
||||
RISPERIDONE, |
||||
| 185 | 26928280 |
US |
43 | 1 |
No adverse event, Product storage error, |
||||
VEDOLIZUMAB, ALLOPURINOL, VALSARTAN, VALSARTAN ORAL, ERGOCALCIFEROL, |
||||
| 186 | 26928459 |
US |
||
Product storage error, No adverse event, |
||||
TOCILIZUMAB, |
||||
| 187 | 26928690 |
US |
67 | 1 |
Product dose omission issue, No adverse event, Inability to afford medication, |
||||
SITAGLIPTIN, |
||||
| 188 | 26928864 |
US |
||
No adverse event, Device malfunction, No adverse event, Device malfunction, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 189 | 26928979 |
US |
||
No adverse event, Device malfunction, No adverse event, Device malfunction, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 190 | 26929007 |
US |
73 | |
Wrong technique in device usage process, Drug dose omission by device, Wrong technique in product usage process performed in error, Prescription drug used without a prescription, Device delivery system issue, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 191 | 26929057 |
US |
||
Product dispensing error, No adverse event, |
||||
POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES, SERTRALINE, LOSARTAN, |
||||
| 192 | 26929082 |
US |
68 | |
Incorrect route of product administration, No adverse event, |
||||
TIOTROPIUM BROMIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, PREDNISONE, |
||||
| 193 | 26929136 |
US |
||
Incorrect dose administered, No adverse event, |
||||
FARICIMAB, FARICIMAB, FARICIMAB, FARICIMAB, |
||||
| 194 | 26929180 |
US |
||
Recalled product administered, No adverse event, |
||||
PREDNISOLONE ACETATE, PREDNISOLONE ACETATE, PREDNISOLONE ACETATE, PREDNISOLONE ACETATE, PREDNISOLONE ACETATE, PREDNISOLONE ACETATE, PREDNISOLONE ACETATE, |
||||
| 195 | 26930067 |
US |
2 | |
Off label use, No adverse event, |
||||
BEVACIZUMAB, |
||||
| 196 | 26930218 |
US |
1 | |
Drug ineffective, No adverse event, |
||||
OMALIZUMAB, |
||||
| 197 | 26930223 |
US |
2 | |
Off label use, Product prescribing error, No adverse event, |
||||
OMALIZUMAB, OMALIZUMAB, ACYCLOVIR, FLUCONAZOLE, LISINOPRIL, PSYLLIUM HUSK, PREDNISONE, MONTELUKAST SODIUM, LEVOTHYROXINE SODIUM, ALBUTEROL SULFATE, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, |
||||
| 198 | 26930243 |
US |
1 | |
Drug ineffective, No adverse event, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 199 | 26930244 |
US |
1 | |
Product dose omission issue, Device use error, No adverse event, Off label use, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CARBIDOPA AND LEVODOPA, LISINOPRIL, HYDROCHLOROTHIAZIDE, CETIRIZINE HYDROCHLORIDE, |
||||
| 200 | 26930252 |
US |
43 | 2 |
Product dose omission issue, Off label use, Device use issue, Product dispensing error, No adverse event, |
||||
OMALIZUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30